Biapharm joins Johnson & Johnson
The French subsidiary of Johnson & Johnson will acquire
Biapharm, a producer and marketer of skin care products centered on
the leading brand Biafine, at the end of September.
Biapharm, a producer and marketer of skin care products centered on
the leading brand Biafine, at the end of September.
Based in Issy-Les-Moulineaux, Johnson & Johnson Consumer France markets well known skin care brands such as RoC and Neutrogena, as well as the Compeed wound care brand.
The terms of the acquisition were not disclosed, but the company said in a statement that it expected the deal to be completed by the end of September.
The Biapharm Group's leading brand, Biafine, is the best known skin healing brand on the French market - within the medical world and in households - and is widely used as a radiotherapy burns healing product.
Laboratoire Medix, the group's main operating company, markets products such as the skin care brand Aloplastine and Effidia, a scab-healing product.